Labcorp Holdings Inc. (LH) has a MoatMap StockRank of 89/100 based on Quality (59/100), Value (50/100), and Momentum (64/100) factor scores. The current signal is STRONG BUY. Labcorp Holdings, providing clinical laboratory and diagnostic services, lacks a direct, strong, and asymmetric macro inflection point from the identified high-conviction themes. Healthcare is generally defensive but not a primary beneficiary of these specific macro shifts.
Labcorp Holdings Inc. is a leading global life sciences company providing comprehensive clinical laboratory services and drug development solutions. Its extensive network of laboratories, broad test menu, and significant scale create efficiencies and brand loyalty. Labcorp is a dual-focused healthcare giant, operating as both a major clinical diagnostic provider and a contract research organization.
| Price | $258.25 |
| Market Cap | $21.3B |
| P/E (TTM) | 22.89 |
| P/E (Forward) | 13.29 |
| Price/Book | 2.46 |
| Return on Equity | 11.0% |
| Return on Invested Capital | 8.6% |
| Debt/Equity | 83.41 |
| Gross Margin | 28.8% |
| Operating Margin | 10.9% |
| Revenue Growth | 5.8% |
| Dividend Yield | 1.1% |
| Free Cash Flow | $1.1B |
Labcorp Holdings Inc. operates in the Diagnostics & Research industry, part of the Healthcare sector (United States).